IGF1R and neoplasm: MiR-342-3p directly targets the 3′UTR of IGF-1R (insulin-like growth factor receptor) acting as a potent tumour suppressor in hepatocellular carcinoma through inhibition of IGF-1R-mediated PI3K/Akt/GLUT1 signalling pathway [171].